Peripartum cardiomyopathy in Iraq: initial registry ‐based data and 6 month outcomes

ConclusionsAround half of our PPCM patients were diagnosed at post-partum period with impaired initial LVEF and GLS, and one-third had early LVEF recovery at 6  month follow-up, higher than that in the Middle East but lower than the globally reported figure in the EORP-PPCM registry. Limited use of bromocriptine might explain the later finding. The co-morbid diseases in our setting were hypertension and cholelithiasis. Interestingly, the comparable ratios of neonatal and maternal mortalities in our study to that of the EORP-PPCM registry were found less than the Middle East figures. Bromocriptine needs to be considered in Middle East countries, including Iraq, which may be the key to improving LVEF recovery and perhaps reducing maternal mortality.

Source: ESC Heart Failure - June 29, 2021 Category: Cardiology Authors: Hasan Ali Farhan, Israa Fadhil Yaseen Tags: Original Research Article Source Type: research